✦ LIBER ✦

Syndecan 1 (CD138) serum levels: a novel biomarker in predicting liver fibrosis stage in patients with hepatitis C

✍ Scribed by Isabel Zvibel; Phillipe Halfon; Sigal Fishman; Guillaume Penaranda; Moshe Leshno; Anat Bet Or; Zamir Halpern; Ran Oren

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatic expression and serum levels of s

✍ Yilmaz, Yusuf; Eren, Fatih; Colak, Yasar; Senates, Ebubekir; Celikel, Cigdem Ata 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 159 KB

1332 HEPATIC EXPRESSION AND SERUM LEVELS

✍ Yilmaz, Y.; Eren, F.; Colak, Y.; Senates, E.; Celikel, C.A.; Imeryuz, N. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Novel Serum Biomarker Candidates for Liv

✍ Gangadharan, B.; Antrobus, R.; Dwek, R. A.; Zitzmann, N. 📂 Article 📅 2007 🏛 American Association for Clinical Chemistry 🌐 English ⚖ 281 KB

Su1191 Soluble Syndecan-1 (CD138) - A No

✍ Yablecovitch, Doron; Stein, Assaf; Naftali, Timna; Gabay, Gila; Laish, Ido; Benj 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 455 KB

P143 Soluble syndecan-1 (CD138) – a nove

✍ Yablecovitch, D.; Stein, A.; Naftali, T.; Gabay, G.; Laish, I.; Konikoff, F. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 52 KB

575 Oninvasive prediction of fibrosis by

✍ Yukiko Saitou; Katsuya Shiraki; Tomoyuki Kawakita; Hidekazu Inoue; Hiroshi Okano 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB